Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.060 AlteredExpression disease BEFREE Evidence is presented that the expression levels of aldehyde dehydrogenase 2 family member, cytochrome P450 family 2 subfamily C member 8, alcohol dehydrogenase 4 (class II), pi polypeptide, alcohol dehydrogenase 1B (class I), β polypeptide and cytochrome P450 family 2 subfamily C member 9 were associated with the overall survival of patients with HCC and that the expression levels of pituitary tumor‑transforming 1, cell division cycle 20, DNA topoisomerase II α and cyclin B2 were negatively associated with the overall survival of patients with HCC. 30720105 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.060 Biomarker disease BEFREE Bioinformatic analysis reveals CYP2C9 as a potential prognostic marker for HCC and liver cancer cell lines suitable for its mechanism study. 29974848 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.060 Biomarker disease BEFREE In conclusion, the present study revealed that CCR7, CCL5, CYP2C9 and CYP2A6 are novel genes identified in the development of HCC; however, the actual functions of these genes require verification. 29436633 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.060 Biomarker disease BEFREE In TCGA database, joint effects analysis of CYP2C8, CYP2C9, and CYP2C19 showed that the risk of death from HCC was lower for groups C and D than for group A (adjusted P = 0.012 and P = 0.008, respectively). 29479826 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.060 Biomarker disease BEFREE Altogether, the study helped to elucidate the mechanism of CYP2C9 regulation by hsa-miR-128-3p, and the inverse association in HCC. 25704921 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.060 AlteredExpression disease BEFREE The first group contained 11 CYPs, including the CYP2C and CYP4F families, that showed decreased expression in parallel with progression of HCV-infected liver to HCC with less differentiation. 16077914 2005